Curay, the top FDA drug regulator, acknowledged that much is still in flux at the agency and introduced a new deputy.

The decision by Health and Human Services Secretary Robert F. Kennedy Jr. to remove and replace all members of the government ...

Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy ...

Regeneron is hoping a new program will widen patient access to its eye drug without also benefiting the company's rivals — a ...

A polymer-based device cleared by the FDA offers physicians a new way for repairing peripheral nerve injuries.

WASHINGTON — A key Senate health leader is calling for this week’s meeting of the panel of vaccine advisers handpicked by ...

This is the web edition of D.C. Diagnosis, STAT's twice-weekly newsletter about the politics and policy of health and ...

In one of the most substantial deals of the year so far, Abridge on Tuesday announced it raised a $300 million Series E ...

We have had the ability to prevent nearly all cases of measles for more than 60 years. Yet the number of cases keeps growing.

The U.S. may be headed for a “choose your own adventure” approach to vaccine policy, in which skeptical parents follow the ...

She wrote that she decided to leave the agency after taking a recent vacation, and thanked staff for their “unwavering ...

Despite a significant increase in injections, today's vaccines expose children to a fraction of the immune-stimulating ...